UNI-EN 10:Current report 10 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 10 | / | 2014 | | ||||||
| Date of issue: | 2014-01-27 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 10 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time Operation Number Unit price of the of shares settlement (BGN) 23.01.2014 Buy 40 3.920 23.01.2014 Buy 960 3.920 20.01.2014 Sale 500 3.975 20.01.2014 Sale 300 3.975 20.01.2014 Sale 200 3.975 21.01.2014 Sale 100 3.975 21.01.2014 Sale 600 3.965 21.01.2014 Sale 370 3.965 21.01.2014 Sale 230 3.965 22.01.2014 Sale 1500 3.95 22.01.2014 Sale 300 3.955 22.01.2014 Sale 500 3.95 22.01.2014 Sale 1000 3.95 22.01.2014 Sale 200 3.955 22.01.2014 Sale 1000 3.95 24.01.2014 Sale 400 3.95 24.01.2014 Sale 400 3.95 24.01.2014 Sale 250 3.94 24.01.2014 Sale 300 3.94 24.01.2014 Sale 100 3.94 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 10 re insiders transactions.doc Current report 10 re insiders transactions.doc | Current report 10 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2014-01-27 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
